AMAN compared with GUTS: revenue, margins and what each company keeps, and the suppliers and customers both name

AMANAmanat Acquisition Corp.

Mkt capRevenueRevenue

GUTSFractyl Health, Inc.

Mkt capRevenueRevenue

Compare

AMANAmanat Acquisition Corp.

GUTSFractyl Health, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMAN

No earnings history for AMAN.

GUTS1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+3.97%—

= impliedAMAN realized, solidGUTS realized, hatchedOne scale, both sides: full bar = 4%× = |realized| ÷ impliedSource: market data

AMANAmanat Acquisition Corp.

10.20▲+0.49%· post 10.13

Mkt cap$54.6MRevenue—Revenue—

GUTSFractyl Health, Inc.

0.92▲+3.16%· post 0.92

ClosedNov 6 '26

Mkt cap$12.3MRevenue$3,000Q4 FY24Revenue$93,000FY24

Compare

ClosedNov 6 '26

AMANAmanat Acquisition Corp.

GUTSFractyl Health, Inc.

10.20▲+0.49%post 10.13

Price

0.92▲+3.16%post 0.92

$54.6M

Mkt cap

$12.3M

—

Revenue

$3,000Q4 FY24

—

Revenue

$93,000FY24

AMAN10.20▲+0.49%vsGUTS0.92▲+3.16%ClosedNov 6 '26